news - International Biopharmaceutical Industry

Current Edition

news

PharmaMar, Chugai terminate License Agreement for Zepsyre

PharmaMar announces that both Chugai and PharmaMar have entered into a mutual early termination agreement of this license agreement Chugai Pharmaceutical Co., Ltd. ...

29 June 2018 news agreement | chugai

Continue Reading →

news

Plasticell leads gene therapy manufacturing consortium

UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo gene therapies. Plasticell, a developer of st...

29 June 2018 news consortium | gene

Continue Reading →

news

NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S

NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 mill...

29 June 2018 news 20 | CHF

Continue Reading →

news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...

29 June 2018 news alvogen | announce

Continue Reading →

news

Immunotherapy advances spur new look at cancer vaccines

In an era of cancer immunotherapy, vaccines are getting fresh consideration as a therapeutic approach. Frustrated for years by lackluster results, cancer vaccine res...

29 June 2018 news advances | cancer

Continue Reading →

news

Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors

Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies,...

29 June 2018 news appoints | board

Continue Reading →

news

Lupin, Mylan to commercialize Enbrel Biosimilar

Under the terms of the agreement, Lupin will receive an up-front payment of $15 million. Pharma major Lupin Limited and global pharmaceutical company Mylan have a...

29 June 2018 news Biosimilar | commercialize

Continue Reading →

news

Aptamer Group: UK Biotech Business Raises $2.2M Investment

Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from ...

29 June 2018 news $2.2M | Aptamer

Continue Reading →

news

CellGenix Completed First Step of Facility Expansion to Stay on Top of the Increasing Demands for GMP Cell Culture Reagents

CellGenix, a global manufacturing leader of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, successfully completed the first ph...

22 June 2018 news cellgenix | completed

Continue Reading →

news

The International Society for Stem Cell Research brings researchers together in Melbourne

The conference is the world’s largest stem cell meeting and will attract more than 2,500 delegates from 60 countries, delivering around $13 million in economic impact...

22 June 2018 news cell | conference

Continue Reading →